Design and one-pot and microwave-assisted synthesis of 2-amino/5-aryl-1,3, 4-oxadiazoles bearing a benzimidazole moiety as antioxidants

Archiv der Pharmazie

Volumn 345, Issue 7, 2012, Pages 549-556

  Kerimov, Ägar ^a   Ayhan Kälcägil, Gülgün ^a   Özdamar, Elçin Deniz ^a   Can Eke, Benay ^a   Çoban, Tülay ^a   Özbey, Süheyla ^b   Kazak, Canan ^c  

^a ANKARA UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Antioxidant activity; Benzimidazoles; Oxadiazoles; X ray

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 1,3,4 OXADIAZOLE DERIVATIVE; 2 AMINO 1,3,4 OXADIAZOLE DERIVATIVE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 METHYL] 5(4 FLUOROPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5 2 TOLYL 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5 3 TOLYL 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5 4 TOLYL 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(2 CHLOROPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(2 FLUORO 5 NITROPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(2,4 DICHLOROPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(3 CHLOROPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(3 CYANOPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(3 NITRO 4 CHLOROPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(4 BROMOPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(4 CHLOROPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(4 ETHYLPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(4 FLUOROPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(4 METHOXYPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(4 NITROPHENYL) 1,3,4 OXADIAZOLE; 2[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZOLE 1 YL) METHYL] 5(4 TRIFLUOROMETHYLPHENYL) 1,3,4 OXADIAZOLE; 5 ARYL 1,3,4 OXADIAZOLE DERIVATIVE; 5[(2 (4 BENZYLOXYPHENYL) 1H BENZO [D] IMIDAZO 1 YL) METHYL] 1,3,4 OXADIAZOLE 2 AMINE; 5[(2 PHENYL) 1H BENZO [D] IMIDAZO 1 YL) METHYL] 1,3,4 OXADIAZOLE 2 AMINE; 5[(2(4 CHLOROPHENYL) 1H BENZO [D] IMIDAZO 1 YL) METHYL] 1,3,4 OXADIAZOLE 2 AMINE; 5[(2(4 METHOXYPHENYL) 1H BENZO [D] IMIDAZO 1 YL) METHYL] 1,3,4 OXADIAZOLE 2 AMINE; ANTIOXIDANT; BENZIMIDAZOLE DERIVATIVE; ETHOXYRESORUFIN DEETHYLASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; IN VITRO STUDY; LIPID PEROXIDATION; MICROSOME; MICROWAVE RADIATION; ONE POT SYNTHESIS; PRIORITY JOURNAL;

EID: 84863706850     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201100440     Document Type: Article

References (39)

1. B. Halliwell, Nutr. Rev. 1994, 52, 253-265.
2. B. Halliwell, Annu. Rev. Nutr. 1996, 16, 33-50.
3. L. A. Pham-Huy, H. He, C. Pham-Huy, Int. J. Biomed. Sci. 2008, 4, 89-96.
4. M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, M. Mazur, Chem. Biol. Interact. 2006, 160, 1-40.
5. D. Kumar, S. Sundaree, E. O. Johnson, K. Shah, Bioorg. Med. Chem. Lett. 2009, 19, 4492-4494.
6. R. Kumar, A. Kumar, S. Jain, D. Kaushik, Eur. J. Med. Chem. 2011, 46, 3543-3550.
7. A. Rauf, S. Sharma, S. Gangal, Chin. Chem. Lett. 2008, 19, 5-8.
8. A. Zarghi, S. A. Tabatabai, M. Faizi, A. Ahadian, P. Navabi, V. Zanganeh, A. S. A. Shafiee, Bioorg. Med. Chem. Lett. 2005, 15, 1863-1865.
9. F. Macaev, G. Rusu, S. Pogrebnoi, A. Gudima, E. Stingaci, L. Vlad, N. Shvets, F. Kandemirli, A. Dimoglo, R. Reynolds, Bioorg. Med. Chem. 2005, 13, 4842-4850.
10. M. Amir, K. Shikha, Eur. J. Med. Chem. 2004, 39, 535-545.
11. S. V. Bhandari, K. G. Bothara, M. K. Raut, A. A. Patil, A. P. Sarkate, V. J. Mokale, Bioorg. Med. Chem. 2008, 16, 1822-1831.
12. A. Husan, M. Ajmal, Acta Pharm. 2009, 59, 223-233.
13. T. M. C. Tan, Y. Chen, K. H. Kong, J. Bai, Y. Li, S. G. Lim, T. H. Ang, Y. Lam, Antiviral Res. 2006, 71, 7-14.
14. M. Saitoh, J. Kunitomo, E. Kimura, Y. Hayase, H. Kobayashi, N. Uchiyama, T. Kawamoto, T. Tanaka, C. D. Mol, D. R. Dougan, G. S. Textor, Bioorg. Med. Chem. 2009, 17, 2017-2029.
15. M. Dabiri, P. Salehi, M. Baghbanzadeh, M. Bahramnejad, Tetrahedron Lett. 2006, 47, 6983-6986.
16. A. P. Andrushko, A. M. Demchenko, A. N. Krasovskii, E. B. Rusanov, A. N. Chernega, M. O. Lozinskii, Russ. J. Gen. Chem. 2000, 71, 1754-1758.
17. H. M. Hassaneen, S. M. S. Atta, N. M. Fawzy, F. A. Ahmed, A. G. Hegazi, F. A. Abdalla, A. H. A. E. Rahman, Arch. Pharm. 2002, 6, 251-261.
18. A. Saeed, Chem. Heterocycl. Compd. 2007, 43, 1072-1075.
19. F. V. Priya, K. S. Girish, B. Kalluraya, J. Chem. Sci. 2007, 119, 41-46.
20. Z. Li, Y. Xing, X. Ma, S. Xiao, Z. Lu, Synth. Commun. 2006, 36, 3287-3295.
21. A. P. Swain, US 2,883,391, 1959.
22. A. Saeed, A. Mumtaz, Chin. Chem. Lett. 2008, 19, 423-427.
23. J. Gowda, A. M. A. Khadar, B. Kalluraya, N. S. Kumari, Indian J. Chem. 2010, 49B, 1130-1134.
24. C. Kus, G. Ayhan-Kilcigil, B. Can-Eke, M. Iscan, Arch. Pharm. Res. 2004, 27, 156-163.
25. G. Ayhan-Kilcigil, C. Kus, T. Coban, B. Can-Eke, M. Iscan, J. Enzyme Inhib. Med. Chem. 2004, 19, 129-135.
26. G. Ayhan-Kilcigil, C. Kus, T. Coban, B. Can-Eke, S. Ozbey, M. Iscan, J. Enzyme Inhib. Med. Chem. 2005, 20, 503-514.
27. G. Ayhan-Kilcigil, C. Kus, E. D. Özdamar, B. Can-Eke, M. Ä°şcan, Arch. Pharm. 2007, 340, 607-611.
28. I. Kerimov, G. Ayhan-Kilcigil, B. Can-Eke, N. Altanlar, M. Iscan, J. Enzyme Inhib. Med. Chem. 2007, 22, 696-701.
29. C. Kuş, G. Ayhan-Kilcigil, S. Özbey, F. B. Kaynak, M. Kaya, T. Çoban, B. Can-Eke, Bioorg. Med. Chem. 2008, 16, 4294-4303.
30. C. Kuş, G. Ayhan-Kilcigil, M. Tunçbilek, N. Altanlar, T. Çoban, B. Can-Eke, M. Ä°şcan, LDDD 2009, 6, 374-379.
31. J. K. Johnson, 1976, ORTEP II. Report. ORNL-5138 Oak Ridge National Laboratory, Tennessee, USA.
32. M. Iscan, E. Arinc, N. Vural, M. Iscan, Comp. Biochem. Physiol. 1984, 77C, 177-190.
33. E. D. Wills, Biochem. J. 1966, 99, 667-676.
34. E. D. Wills, Biochem. J. 1969, 113, 333-341.
35. S. Bishayee, A. S. Balasubramanian, J. Neurochem. 1971, 18, 909-920.
36. M. D. Burke, S. Thompson, C. R. Elcombe, J. Halpert, T. Haaparanta, R. T. Mayer, Biochem. Pharmacol. 1985, 34, 3337-3345.
37. M. S. Blois, Nature 1958, 181, 1199-1200.
38. G. M. Sheldrick, 1997, SHELXS97. Program for Crystal Structure Solution. University of Göttingen, Germany.
39. G. M. Sheldrick, 1997, SHELXL97. Program for Crystal Structure Refinement, University of Göttingen, Germany.